Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

804
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
804
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.

Acta neuropsychiatrica·2026
Same author

Efficacy of N, N-dimethyltryptamine (DMT) psychedelic therapy for substance misuse: A systematic review and meta-analysis.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarction.

Open heart·2026
Same author

Childhood post-adoption experiences and the long-term trajectories of deprivation-specific neurodevelopmental problems: a longitudinal study of the English and Romanian adoptee cohort.

European child & adolescent psychiatry·2026
Same author

Administration of EAPCI patient video animation versus standard patient information leaflets in the catheterization laboratory: Impact on patient experience assessed using the PATCATH questionnaire.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Genetic predisposition to elevated lipoprotein(a) in early-onset myocardial infarction.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Dec 31, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.3K

Complex type 2 diabetes mellitus--management challenges and pitfalls.

Mark Kennedy1, Adam Roberts

  • 1Corio Medical Clinic, Geelong, Victoria. mfgkennedy@coriomedical.com.au

Australian Family Physician
|April 4, 2013
PubMed
Summary

Managing type 2 diabetes mellitus in complex patients requires careful consideration of comorbidities like cardiovascular disease and renal impairment. General practitioners can effectively tailor treatment plans by assessing individual patient risks, benefits, and motivation.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.4K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Related Experiment Videos

Last Updated: Dec 31, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.3K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.4K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Area of Science:

  • Internal Medicine
  • Endocrinology
  • General Practice

Background:

  • Type 2 diabetes mellitus (T2DM) management is complicated by frequent comorbidities.
  • Patients often require multiple medications for hyperglycemia, hypertension, and other conditions.
  • Progressive renal failure and cardiovascular disease necessitate complex medication adjustments and management of adverse effects.

Purpose of the Study:

  • To explore challenges in managing complex T2DM patients.
  • To address issues of non-adherence and achieving glycemic control.
  • To examine difficulties in patients with cardiovascular disease and renal impairment.

Main Methods:

  • Literature review and clinical case analysis.
  • Exploration of treatment strategies for complex T2DM patients.
  • Discussion of risk-benefit assessment in medication management.

Main Results:

  • Complex T2DM patients present significant management challenges.
  • Non-adherence and comorbidities like cardiovascular disease and renal impairment complicate glycemic control.
  • Tailoring therapy to individual patient needs, including motivation, is crucial.

Conclusions:

  • General practitioners are well-positioned to manage complex T2DM patients.
  • Effective management requires assessing risks and benefits of treatment decisions.
  • Consideration of glycemic control, cardiovascular status, renal function, and patient motivation is essential.